UK markets close in 8 hours 3 minutes

Nuo Therapeutics, Inc. (AURX)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.75000.0000 (0.00%)
At close: 09:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
782.002
608.525
112.25
0
0
-
Cost of revenue
166.264
126.092
19.214
0
0
-
Gross profit
615.738
482.433
93.036
0
0
-
Operating expenses
Research development
-
-
-
0
0
181.185
Selling general and administrative
3,638
3,651
3,414
90.67
378.059
-
Total operating expenses
3,638
3,651
3,414
90.67
378.059
-
Operating income or loss
-3,022
-3,168
-3,321
-90.67
-378.059
-
Interest expense
-
3.162
2.103
0
48.39
-
Total other income/expenses net
-
-
150.961
-
335.579
-4.237
Income before tax
-3,024
-3,171
-3,172
-90.67
-90.87
-
Income tax expense
-
-
-
0
0
0
Income from continuing operations
-3,024
-3,171
-3,172
-90.67
-90.87
-
Net income
-3,024
-3,171
-3,172
-90.67
-90.87
-
Net income available to common shareholders
-3,024
-3,171
-3,172
-886.262
7,709
-
Basic EPS
-0.08
-0.08
-0.08
-0.03
0.30
-
Diluted EPS
-0.08
-0.08
-0.08
-0.03
0.27
-
Basic average shares
41,891
42,078
40,001
30,296
25,692
-
Diluted average shares
41,891
42,078
40,001
30,296
27,312
-